Weight loss medication impact on Brazilian consumer habits

The increasing use of injectable weight loss medications in Brazil is driving significant changes in consumer dietary habits and food industry demands. National data indicates that a vast majority of users are reducing their intake of ultra-processed goods and industrialized products, with many prioritizing protein sources to mitigate muscle mass loss.

Regional studies, such as those in Campo Grande, reflect these broader trends. Research shows that medication users frequently prefer smaller portions and report higher consumption of vegetables and proteins, alongside a reduction in sweets and desserts. While appetite decreases, some users report stable or increased frequencies of dining out, suggesting a need for the food service sector to adapt menus to these nutritional shifts.

Beyond consumer behavior, the trend is impacting the agribusiness sector, particularly in regions like Paraná, due to rising demand for high-quality proteins such as meat, eggs, and legumes. On a policy level, the Brazilian government is considering the potential incorporation of these treatments into the Unified Health System (SUS) for patients with medical indications for obesity.